Drug Delivery and Development of Anti-HIV Microbicides

José das Neves has a PhD in pharmaceutical sciences from the University of Porto, Portugal. He is a researcher at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, Portugal and Faculty of Pharmacy, University of Porto, Portugal. His current research interests include vaginal drug delivery and the development of nanotechnology-based solutions for the development of anti-HIV microbicides. Bruno Sarmento has a PhD in pharmaceutical technology from the University of Porto, Portugal. He is an affiliated researcher at INEB – Instituto de Engenharia Biomédica, University of Porto, Portugal and assistant professor of pharmaceutical and biopharmaceutical technology at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, Portugal. His current research focuses on nanomedicines and their application in the pharmaceutical and biomedical fields.

Preface. Microbicides and the HIV Pandemic. HIV Transmission Models: Lessons Learned for Microbicide Formulation Design. Challenges in Microbicide Drug Delivery: Identifying Targets and Evolving Strategies. Safety Issues Related with Microbicide Formulations. Biophysics, Drug Transport Modeling and Performance of Microbicide Formulations. Dosage Forms for Microbicides Formulation: Advantages and Pitfalls. Microbicide Vaginal Rings. Vaginal Microbicide Films. Rectal Microbicide Development, Formulation and Delivery. Design of Stimuli-Sensitive Microbicide Formulations. Nanotechnology-Based Systems for Microbicide Development; Nanofibers for Microbicide Drug Delivery. Modified Microflora for Microbicide Drug Delivery. Scale-up, Affordability and Intellectual Property Issues Related with Microbicide Formulation Development. Regulatory Issues Pertaining Microbicide Products.Socioeconomic and Behavioral Factors Influencing Choice, Adherence and Success of Microbicide Formulations.